Company intelligence
HaemaLogiX Ltd
Focusing on the development and commercialisation of novel immuno-oncology and immune-therapies.
Biotechnology
Sydney, AU
7 employees
Founded 2014
1 public signals
About HaemaLogiX Ltd
HaemaLogiX focus is the development and commercialisation of novel immuno-oncology and immune-therapies. HaemaLogiX is embarking on a program of several inter-related research and clincial development projects that will validate the antigen targets and products. We have a unique opportunity to develop effective treatments that improve the quality of life of patients suffering from blood cancers and autoimmune diseases.
Verified activity
Signals from HaemaLogiX Ltd
1 published signal